The line between pharmaceuticals and technology is blurring as companies join forces to tackle chronic diseases using high-tech devices that combine biology, software and hardware.
GlaxoSmithKline (GSK.L) and Google parent Alphabet (GOOGL.O) are the latest to share expertise, unveiling a new joint company on Monday that aims to market bioelectronic devices to fight illness by attaching to individual nerves.
Source: Reuters
Filed Under: Drug Discovery
